Market Overview:
The global medical devices used for opioid use disorder and drug addiction treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of opioid use disorders and drug addiction, rising awareness about available treatments, and technological advancements in medical devices used for treating these disorders. The global medical devices used for opioid use disorder and drug addiction treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into pirfenidone and nintedanib. On the basis of application, the market is segmented into hospital settings and clinic settings.
Product Definition:
Medical devices used for opioid use disorder and drug addiction treatment are important because they can help to manage the symptoms of opioid use disorder and drug addiction. They can also help people to recover from these conditions.
Pirfenidone:
Introduction of new technologies for the development of novel drugs and devices is a key factor expected to drive market growth over the forecast period. The introduction of new technologies in combination with other therapies has led to an increase in the efficiency and effectiveness of medical treatments used for opioid use disorder and drug addiction treatment.
Nintedanib:
Nintedanib is an opioid use disorder treatment drug that works by blocking the re-absorption of norepinephrine and dopamine in the brain. It was approved by the FDA in 2015 for treating patients who have been treated with other opioid therapy but who are still experiencing symptoms of addiction. Nintedanib has also been found to be effective in reducing cravings and preventing relapse among individuals addicted to opioids, which makes it a promising drug for treating addictions.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and other. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of opioid use disorder and drug addiction across various regions including North America and Europe. Moreover, an increase in healthcare spending due to growing geriatric population coupled with rising number of chronic diseases such as cancer will boost demand for devices used for opioid use disorder and drug addiction treatment at hospitals globally.
The Clinic segment is expected to grow at a lucrative rate over the forecast period owing to increasing awareness about effective pain management techniques along with rising availability of advanced medical equipment such as imaging systems which can assist patients suffering from chronic pain conditions get proper diagnosis without visiting hospitals frequently.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high adoption rate for advanced technologies. The region is expected to maintain its dominance over the forecast period due to increasing government funding for opioid addiction treatment, rising awareness about available treatment options, and growing demand for effective pain management solutions.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare infrastructure, rising prevalence of chronic diseases & disorders coupled with an increase in geriatric population that requires long-term care & support. These factors are likely drive regional market growth over the next eight years.
Growth Factors:
- Increasing incidence of opioid use disorder and drug addiction
- Growing awareness about the benefits of medical devices used for opioid use disorder and drug addiction treatment
- Rising demand for minimally invasive treatments for opioid use disorder and drug addiction
- Technological advancements in medical devices used for opioid use disorder and drug addiction treatment
- increasing funding for research on medical devices used for opioid use disorder and drug addiction treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Research Report
By Type
Pirfenidone, Nintedanib
By Application
Hospital, Clinic
By Companies
Boehringer Ingelheim, Roche, FibroGen, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, MediciNova, Inc., Genentech, Inc., Cipla Inc., Biogen, Galapagos NV
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Report Segments:
The global Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment market is segmented on the basis of:
Types
Pirfenidone, Nintedanib
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Roche
- FibroGen, Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- MediciNova, Inc.
- Genentech, Inc.
- Cipla Inc.
- Biogen
- Galapagos NV
Highlights of The Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pirfenidone
- Nintedanib
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical devices are used for opioid use disorder and drug addiction treatment in a variety of ways. Some medical devices help patients manage their opioid use by providing them with information about how much opioids they should take, monitoring their medication levels, or delivering the medication directly to the stomach. Other medical devices help patients stop using opioids altogether by providing them with medications that block the effects of opioids or replacing lost function in opioid-dependent individuals.
Some of the major players in the medical devices used for opioid use disorder and drug addiction treatment market are Boehringer Ingelheim, Roche, FibroGen, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, MediciNova, Inc., Genentech, Inc., Cipla Inc., Biogen, Galapagos NV.
The medical devices used for opioid use disorder and drug addiction treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Size & Forecast, 2020-2028 4.5.1 Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Size and Y-o-Y Growth 4.5.2 Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pirfenidone
5.2.2 Nintedanib
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pirfenidone
9.6.2 Nintedanib
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pirfenidone
10.6.2 Nintedanib
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pirfenidone
11.6.2 Nintedanib
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pirfenidone
12.6.2 Nintedanib
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pirfenidone
13.6.2 Nintedanib
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market: Competitive Dashboard
14.2 Global Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 Roche
14.3.3 FibroGen, Inc.
14.3.4 Merck & Co., Inc.
14.3.5 Bristol-Myers Squibb Company
14.3.6 MediciNova, Inc.
14.3.7 Genentech, Inc.
14.3.8 Cipla Inc.
14.3.9 Biogen
14.3.10 Galapagos NV